The U.S. Food and Drug Administration (FDA) on Friday approved two gene therapies for sickle cell disease, including one that is the first treatment in the United States based on the Nobel ...
This summary highlights key events in the health sector, including the mixed results of Gilead's Trodelvy in cancer trials, ...
This health news summary spotlights major developments in cancer treatments, regulatory actions on biotechnology, and the ...
Sarclisa accepted for FDA priority review for the treatment of transplant-ineligible newly diagnosed multiple myeloma FDA Priority Review granted based on positive results from ...